Remove Administration Remove Research Remove Stroke
article thumbnail

52 in 52 – #38: Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke

EMDocs

This week we cover the EXTEND trial looking at thrombolysis up to 9 hours after stroke onset. and 9 hours after onset of symptoms, with non-infarcted brain tissue, does the administration of alteplase improve functional outcome at 90 days? Intervention: Alteplase 0.9 in alteplase group versus 0.9% to 53.54, p=0.053).

Stroke 95
article thumbnail

Unpacking the PEACH Trial: What is Levetiracetam’s Role in Spontaneous Intracerebral Hemorrhage?

RebelEM

BACKGROUND: intracerebral hemorrhage (ICH) makes up 10-15% of all strokes and significantly contributes to overall stroke-related morbidity and mortality ( Hostettler 2019 ). About 30% of patients experience early seizures within seven days following the onset of a stroke ( Peter-Derex 2022 ).

Seizures 123
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Anticoagulant Selection Is Cornerstone of Pulmonary Embolism Treatment

ACEP Now

First, UFH is often perceived as stronger than alternatives, partially owing to the intravenous route of administration. 11 Most patients hospitalized with PE undergo neither CDT nor thrombolysis and, even if they do, administration of LMWH is not a contraindication. Stubblefield WB, Helderman R, Strokes N, et al.

article thumbnail

The Latest Research in Neurologic Emergencies

ACEP Now

This comes out of INTERACT-4, a trial testing the efficacy of blood pressure reduction in undifferentiated acute stroke syndromes. Without delving into too much detail, approximately half of the over 2,300 patients in the trial suffered ischemic stroke, and the remainder hemorrhagic stroke.

article thumbnail

Fourteen Emergency Medicine Research Gems from 2023

ACEP Now

Every year, the volume of published research continues to outpace capacity to consume. What’s New in Stroke Care? The simplicity of tenecteplase administration makes its use likely the preferred agent for treating acute ischemic stroke. the “ARAMIS” trial throws up another red flag for patients suffering mild stroke.

article thumbnail

To Treat or Not to Treat

Sensible Medicine

People can rise through the academic ranks as gifted clinicians, creative and effective educators, and talented administrators. [i] i] Though I’ve never been a traditional researcher, I’ve added quite a bit to “medical literature” over the years. Being perfectly honest, not all the articles have aged well.

Stroke 98
article thumbnail

Blood Pressure Management in Neurologic Emergencies: What Does the Evidence Say?

EMDocs

This article will discuss blood pressure goals and preferred pharmacotherapy for non-traumatic ischemic and hemorrhagic strokes. Ischemic Strokes: Ischemic stroke is characterized by a blockage of a blood vessel in the brain. The BP targets for patients with ischemic strokes depend on the available therapeutic options.

Stroke 91